D P Carbone Selected Research

D P Carbone Research Topics

Disease

12	Neoplasms (Cancer) 01/2021 - 05/2000
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 01/2001
4	Lung Neoplasms (Lung Cancer) 11/2005 - 05/2000
2	Carcinogenesis 07/2005 - 01/2001
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2016
1	Adenocarcinoma of Lung 11/2005
1	Stomach Neoplasms (Stomach Cancer) 05/2005
1	Colonic Neoplasms (Colon Cancer) 07/2001
1	Lymphatic Metastasis 07/2001
1	Colorectal Neoplasms (Colorectal Cancer) 07/2001
1	Hypersensitivity (Allergy) 06/2001
1	Squamous Cell Carcinoma of Head and Neck 03/2001
1	Malaria 01/2000
1	Infections 01/2000

Drug/Important Bio-Agent (IBA)

3	Transforming Growth Factor beta (TGF-beta)IBA 11/2005 - 05/2000
3	Proteins (Proteins, Gene)FDA Link 07/2005 - 01/2000
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2001 - 05/2000
2	NivolumabIBA 12/2021 - 10/2021
2	IpilimumabIBA 12/2021 - 10/2021
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2016 - 01/2010
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 02/2016
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2010
1	Insulin-Like PeptidesIBA 05/2005
1	Amino Acids FDA Link 05/2005
1	Therapeutic UsesIBA 05/2005
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 05/2005
1	LigandsIBA 05/2005
1	SurvivinIBA 08/2004
1	Biomarkers (Surrogate Marker)IBA 08/2004
1	Glycoproteins (Glycoprotein)IBA 07/2001
1	Insulin-Like Growth Factor Binding ProteinsIBA 07/2001
1	tumor-derived adhesion factorIBA 07/2001
1	Immunoglobulin E (IgE)IBA 06/2001
1	IgE Receptors (Fc epsilon RI)IBA 06/2001
1	NF-kappa B (NF-kB)IBA 03/2001
1	Phosphotransferases (Kinase)IBA 03/2001
1	Transcription Factors (Transcription Factor)IBA 03/2001
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2001
1	CarcinogensIBA 01/2001
1	Biological ProductsIBA 01/2001
1	Cisplatin (Platino)FDA LinkGeneric 01/2001
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2001
1	Interleukin-4 (Interleukin 4)IBA 12/2000
1	CytokinesIBA 12/2000
1	Radiation-Sensitizing AgentsIBA 12/2000
1	texaphyrinIBA 12/2000
1	GadoliniumIBA 12/2000
1	Interleukin-13IBA 12/2000
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 12/2000
1	STAT6 Transcription FactorIBA 12/2000
1	Interleukin-10 (Interleukin 10)IBA 05/2000
1	Endothelial Growth FactorsIBA 05/2000
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2000
1	AntibodiesIBA 05/2000
1	Interleukin-6 (Interleukin 6)IBA 05/2000
1	Macrophage Colony-Stimulating FactorIBA 05/2000
1	Blocking AntibodiesIBA 01/2000
1	EpitopesIBA 01/2000

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 12/2021 - 05/2005
3	Therapeutics 01/2021 - 05/2000
2	Immunotherapy 01/2001 - 12/2000
1	Radiotherapy 03/2001
1	Rejuvenation 01/2001